MAMA:NASDAQMama's Creations, Inc. Analysis
Data as of 2026-08-26 - not real-time
$16.63
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
At $16.63, Mama's Creations, Inc. shows no decisive moving-average alignment, leaving the trend neutral. The last 30 days have lost 7.7%. Relative strength is 43.2 — neutral — and the MACD signal is bearish. Price has been bracketed by support at $15.66 and resistance at $19.35.
The shares look overvalued at 110.9 times earnings, though no sector average was available for comparison. Analyst price targets sit 34.9% above the current price. Revenue is growing at 49.7% on a 3.2% profit margin.
On a 1-10 scale the risk profile lands at 5 — moderate. With 30-day volatility of 38.5%, a beta of 0.43 and a maximum drawdown of 24.1%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 2 out of 10.
The shares look overvalued at 110.9 times earnings, though no sector average was available for comparison. Analyst price targets sit 34.9% above the current price. Revenue is growing at 49.7% on a 3.2% profit margin.
On a 1-10 scale the risk profile lands at 5 — moderate. With 30-day volatility of 38.5%, a beta of 0.43 and a maximum drawdown of 24.1%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 2 out of 10.
Top Market Events
Immersion Investment Partners, an investment management company, released its second-quarter 2025 investor letter.It has been about a month since the last earnings report for Mama's Creations, Inc.Riverwater Partners, an investment management company, released its “Micro Opportunities Strategy” Q2 2026 investor...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Trading above the 200-day average of 15.10
- MACD momentum is negative
- 30-day price change of -7.7%
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- Trading above the 200-day average of 15.10
- Analyst targets imply +34.9% versus the current price
- MACD momentum is negative
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- Analyst targets imply +34.9% versus the current price
- Revenue growth of +49.7%
- P/E ratio of 110.9
Key Metrics & Analysis
Financial Health
Revenue Growth49.70%
Profit Margin3.23%
P/E Ratio110.9
ROE14.93%
ROA8.46%
Debt/Equity24.74
P/B Ratio12.2
Op. Cash Flow$10.4M
Free Cash Flow$5.2M
Technical Analysis
TrendNeutral
RSI43.2
Support$15.66
Resistance$19.35
MA 20$17.42
MA 50$17.82
MA 200$15.10
MACDBearish
VolumeStable
Fear & Greed Index93.5
Valuation
Fair Value$4.15
Target Price$22.43
Upside/Downside34.87%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta0.43
Volatility38.53%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.